Select Medical Holdings (FRA:S24) ROE %: 10.23% (As of Mar. 2026) — 43% Below Median


FRA:S24 Select Medical Holdings Corp FRA:S24
77 GF Score
Price €14.40
GF Value €14.99
! 7 Warning Signs
View Full Analysis

What is Select Medical Holdings ROE %?

Select Medical Holdings FRA:S24 +1.41% 77 ROE % is 10.23% as of Mar. 2026, which is 43% below its 10-year median of 17.91. GuruFocus rates FRA:S24 with a GF Score™ of 77/100 and a GF Value™ of €14.99. The stock has 7 warning signs investors should review. Among 626 Healthcare Providers & Services companies, Select Medical Holdings ranks better than 56.55% on this metric.

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Select Medical Holdings's annualized net income for the quarter that ended in Mar. 2026 was €152 Mil. Select Medical Holdings's average Total Stockholders Equity over the quarter that ended in Mar. 2026 was €1,488 Mil. Therefore, Select Medical Holdings's annualized ROE % for the quarter that ended in Mar. 2026 was 10.23%.

The historical rank and industry rank for Select Medical Holdings's ROE % or its related term are showing as below:

FRA:S24' s ROE % Range Over the Past 10 Years
Min: 7.82   Med: 17.91   Max: 37.06
Current: 7.82

During the past 13 years, Select Medical Holdings's highest ROE % was 37.06%. The lowest was 7.82%. And the median was 17.91%.

FRA:S24's ROE % is ranked better than
56.55% of 626 companies
in the Healthcare Providers & Services industry
Industry Median: 5.805 vs FRA:S24: 7.82

Select Medical Holdings  (FRA:S24) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Mar. 2026 )
=Net Income/Total Stockholders Equity
=152.224/1487.7635
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(152.224 / 4918.308)*(4918.308 / 5111.8295)*(5111.8295 / 1487.7635)
=Net Margin %*Asset Turnover*Equity Multiplier
=3.1 %*0.9621*3.4359
=ROA %*Equity Multiplier
=2.98 %*3.4359
=10.23 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Mar. 2026 )
=Net Income/Total Stockholders Equity
=152.224/1487.7635
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (152.224 / 284.04) * (284.04 / 340.528) * (340.528 / 4918.308) * (4918.308 / 5111.8295) * (5111.8295 / 1487.7635)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.5359 * 0.8341 * 6.92 % * 0.9621 * 3.4359
=10.23 %

Note: The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Select Medical Holdings ROE % Related Terms


Select Medical Holdings ROE % Historical Data

* Premium members only.

The historical data trend for Select Medical Holdings's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Select Medical Holdings ROE % Chart

Select Medical Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 38.40 14.70 19.93 14.67 8.16

Select Medical Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.12 9.27 6.80 4.76 10.23

FRA:S24 vs SGRY, MD, AGL: ROE % Comparison

For the Medical Care Facilities subindustry, Select Medical Holdings's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Select Medical Holdings ROE % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Select Medical Holdings's ROE % distribution charts can be found below:

* The bar in red indicates where Select Medical Holdings's ROE % falls into.


FRA:S24
77GF Score
Select Medical Holdings Corp FRA:S24
ROE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Select Medical Holdings ROE % Calculation

Select Medical Holdings's annualized ROE % for the fiscal year that ended in Dec. 2025 is calculated as

ROE %=Net Income (A: Dec. 2025 )/( (Total Stockholders Equity (A: Dec. 2024 )+Total Stockholders Equity (A: Dec. 2025 ))/ count )
=124.871/( (1605.694+1456.569)/ 2 )
=124.871/1531.1315
=8.16 %

Select Medical Holdings's annualized ROE % for the quarter that ended in Mar. 2026 is calculated as

ROE %=Net Income (Q: Mar. 2026 )/( (Total Stockholders Equity (Q: Dec. 2025 )+Total Stockholders Equity (Q: Mar. 2026 ))/ count )
=152.224/( (1456.569+1518.958)/ 2 )
=152.224/1487.7635
=10.23 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Mar. 2026) net income data. ROE % is displayed in the 30-year financial page.

Frequently Asked Questions Learn more about ROE % →
What does a ROE % of 10.23% mean?
Select Medical Holdings (FRA:S24) has a ROE % of 10.23% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Select Medical Holdings and its competitors. This is 43% below median its historical median of 17.91. Over the past decade, Select Medical Holdings' ROE % has ranged from 7.82 to 37.06. According to the industry distribution chart, Select Medical Holdings ranks #272 out of 626 companies in the Healthcare Providers & Services industry, placing it in the top 43.5%.
Is Select Medical Holdings' ROE % too high?
Select Medical Holdings' current ROE % of 10.23% is 43% below median its 10-year median of 17.91. Over the past 10 years, this metric has ranged from a low of 7.82 to a high of 37.06. The Healthcare Providers & Services industry median ROE % is 5.81. Select Medical Holdings' value of 10.23% is 76.2% above this industry median. Based on the distribution chart, Select Medical Holdings ranks #272 out of 626 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Select Medical Holdings has a GF Score™ of 77/100, reflecting its overall financial health beyond just this single metric.
How does Select Medical Holdings' ROE % compare to SGRY and MD?
According to the Healthcare Providers & Services industry distribution chart, Select Medical Holdings ranks #272 out of 626 companies for ROE %. This puts Select Medical Holdings in the upper half of its industry. The industry median ROE % is 5.81. Select Medical Holdings' value of 10.23% is 76.2% above this benchmark. Historically, Select Medical Holdings' own ROE % has ranged from 7.82 to 37.06 over the past decade. While the company's 10-year median is 17.91 vs. the industry median of 5.81, Select Medical Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Healthcare Providers & Services company?
The median ROE % among Healthcare Providers & Services companies is 5.81, based on 626 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Select Medical Holdings's current ROE % of 10.23% is 76.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Select Medical Holdings and its competitors. For the Healthcare Providers & Services industry, the median ROE % is 5.81 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Select Medical Holdings's current ROE % is 10.23%, which is 43% below median its own 10-year median of 17.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Select Medical Holdings stock overvalued right now?
Select Medical Holdings (FRA:S24) has a current ROE % of 10.23%. The stock's GF Value™ is €14.99, compared to a current price of €14.40 — trading 3.9% below its estimated fair value. The current ROE % is 10.23%, which is 43% below median its 10-year median of 17.91 and 76.2% above the Healthcare Providers & Services industry median of 5.81. Select Medical Holdings' overall GF Score™ is 77/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Select Medical Holdings (FRA:S24), the current ROE % is 10.23% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Select Medical Holdings (FRA:S24) Overvalued in 2026?

Based on GuruFocus' analysis, Select Medical Holdings stock appears to be undervalued. The current stock price of €14.40 is trading 3.9% below its estimated GF Value™ of €14.99.

Key valuation signals for FRA:S24:

  • ROE %: 10.23% (43% below median its 10-year median of 17.91)
  • GF Value™: €14.99 vs. price of €14.40 (3.9% below fair value)
  • GF Score™: 77/100 with 7 warning signs
  • Industry Position: 76.2% above the Healthcare Providers & Services median (#272 of 626)

No single metric tells the full story. See the FRA:S24 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Select Medical Holdings Business Description

Other Exchanges SEM:USA
Address 4714 Gettysburg Road, P.O. Box 2034, Mechanicsburg, PA, USA, 17055
Select Medical Holdings Corp is a healthcare company that operates through three segments: critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics. Critical illness recovery hospitals which derives maximum revenue consists of hospitals designed to serve the needs of patients recovering from critical illnesses, often with complex medical needs. The rehabilitation hospital segment consists of hospitals designed to serve patients that require intensive physical rehabilitation care. Patients are typically admitted to critical illness recovery hospitals and rehabilitation hospitals from general acute care hospitals. The outpatient rehabilitation segment consists of clinics that provide physical, occupational, and speech rehabilitation services.
77GF Score

Get the complete analysis for FRA:S24

ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€14.40
Price
€14.99
GF Value